Revenue by Geography

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	2011 - 2020
Period Ending	Jun '25 Jun 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	2011 - 2020
Denmark Revenue	-	2.75B	Log In	Log In	Log In	Upgrade
United States Revenue	-	125.29M	Log In	Log In	Log In	Upgrade
Japan Revenue	-	116.82M	Log In	Log In	Log In	Upgrade
Revenue (Total)	22.31B	21.53B	Log In	Log In	Log In	Upgrade

Revenue Breakdown

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	2011 - 2020
Period Ending	Jun '25 Jun 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	2011 - 2020
DARZALEX Royalties Revenue	2.17B	1.93B	Log In	Log In	Log In	Upgrade
Kesimpta Royalties Revenue	369.13M	308.65M	Log In	Log In	Log In	Upgrade
TEPEZZA Royalties Revenue	99.87M	102.37M	Log In	Log In	Log In	Upgrade
Other Product Royalties Revenue	80.75M	65.42M	Log In	Log In	Log In	Upgrade
Total Royalties Revenue	2.72B	2.41B	Log In	Log In	Log In	Upgrade
Reimbursement Revenue	95.31M	138.35M	Log In	Log In	Log In	Upgrade
Milestone Revenue	104.26M	138.90M	Log In	Log In	Log In	Upgrade
Collaboration Revenue	68.53M	60.15M	Log In	Log In	Log In	Upgrade
License Revenue	-	277.81K	Log In	Log In	Log In	Upgrade
Net Product Sales	313.38M	242.11M	Log In	Log In	Log In	Upgrade
Revenue (Other)	16.28B	16.13B	Log In	Log In	Log In	Upgrade
Revenue (Total)	22.31B	21.53B	Log In	Log In	Log In	Upgrade

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	2011 - 2020
Period Ending	Jun '25 Jun 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	2011 - 2020
J&J Revenue	2.26B	2.00B	Log In	Log In	Log In	Upgrade
Roche Revenue	101.42M	102.93M	Log In	Log In	Log In	Upgrade
Novartis Revenue	453.22M	391.99M	Log In	Log In	Log In	Upgrade
BioNTech Revenue	80.01M	120.71M	Log In	Log In	Log In	Upgrade
Pfizer Revenue	79.48M	74.04M	Log In	Log In	Log In	Upgrade
AbbVie Revenue	12.44M	54.73M	Log In	Log In	Log In	Upgrade
Other Collaboration Partner Revenue	2.28M	277.81K	Log In	Log In	Log In	Upgrade
Revenue (Total)	22.31B	21.53B	Log In	Log In	Log In	Upgrade

Updated Jun 30, 2025. Data Source: Fiscal.ai.